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A R T I C L E   I N F O A B S T R A C T 
There is a need to prolong drug residence time using a biocompatible formulation 
in the subconjunctival space after surgery to treat glaucoma. Drug releasing discs 
were prepared with 2-(hydroxyethyl)methacrylate (HEMA) and 2-methacryloyl-
oxyethyl phosphorylcholine (MPC). The ratio of bound water (Wb) to free water 
(Wf) ratio increased from 1:0.3 to 1:6.8 with increasing MPC (0 to 50%, w/w).  The 
optimal balance between water content, SR and mechanical strength were obtained 
with 10% MPC (w/w) hydrogels. Water-alcohol mixtures were examined to 
facilitate loading of poorly soluble drugs, and they showed greater hydrogel 
swelling than either water or alcohol alone. The SR was 1.2 ± 0.02 and 3.3 ± 0.1 for 
water and water:ethanol (1:1) respectively. HEMA-MPC (10%) discs were loaded 
with dexamethasone using either water:ethanol (1:1) or methanol alone. Drug 
release was examined in an outflow rig model that mimics the subconjunctival space 
in the eye. Dexamethasone loading increased from 0.3 to 1.9 mg/disc when the 
solvent was changed from water:ethanol (1:1) to methanol with the dexamethasone 
half-life (t½) increasing from 1.9 to 9.7 days respectively. These encouraging results 
indicate that HEMA-MPC hydrogels have the potential to sustain the residence time 
of a drug in the subconjunctival space of the eye. 
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INTRODUCTION 
There continues to be a need to develop sustained 
release formulations for the subconjunctival and 
periocular spaces (Kuppermann & Loewenstein 2010; 
Kang-Mieler et al. 2014). Glaucoma is the most 
common cause of irreversible blindness in the world 
and the only proven treatment is to decrease the 
intraocular pressure (IOP) to slow progression of 
optic nerve damage (Weinreb & Khaw 2004). 
Glaucoma filtration surgery (GFS) is a procedure to 
create a pathway to drain aqueous humour from the 
eye to lower the IOP. Unfortunately, scarring occurs 
at the site of surgery to block aqueous outflow 
resulting in a rise of IOP (Kimura et al. 1992). The 
outcome of GFS can be improved by the modulation 
of wound healing processes to prevent excessive 
fibroblast proliferation and scarring (Cui et al. 2008).   
 
The use of cytotoxic agents applied during surgery 
has revolutionised the outcomes for GFS (Dhingra & 
Khaw 2009). Localised scarring still remains a 
challenge because subsequent treatment by direct 
injection of less toxic agent into the subconjunctiva 
(Chong et al. 2013) is either not efficacious or practical. 
Drug residence time in the subconjunctival space is 
short because aqueous outflow simply takes the drug 
after injection directly into the conjunctiva and into 
the systemic circulation. Although eye drops are 
widely used for a large number of periocular 
conditions and can be considered for use to treat 
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scarring after GFS (Skuta et al. 1992), we are also 
developing dosage forms designed for ocular 
implantation into the subconjunctival space after GFS 
(Parkinson et al. 2012). Tissue implantable dosage 
forms can result in prolonged local drug exposure 
with a lower cumulative, systemic exposure to the 
drug. One challenge for implantable dosage forms is 
to avoid a foreign body response, which can readily 
occur in tissue that is traumatised by surgery.   
In GFS, another potential function of an implantable 
dosage form would be to act as a barrier within the 
subconjunctival space to separate the conjunctiva 
from the sclera to help maintain pathways for 
aqueous outflow. Glaucoma drainage devices (GDDs) 
are used as an alternative to GFS to shunt aqueous 
outflow from the eye to lower IOP (Bettin & Di Matteo 
2013). Many of these devices have a plate or a spacer 
that sits in the sub-conjunctival space. Silicone is 
commonly used in GDDs but a foreign body response 
around the plate results in scarring that blocks 
aqueous outflow leading to an increased IOP.  
Hydrogels are three dimensional (3D) polymeric 
crosslinked networks that have been widely 
investigated for biomedical applications such as tissue 
engineering, artificial replacement of organs, coating 
of implantable devices, drug delivery, gene delivery, 
scaffolding and wound dressings (Du et al. 2013; 
Vashist et al. 2014; Hoffman 2012). Hydrogels are 
often considered to be broadly biocompatible and are 
widely used in the eye (e.g. contact lens and 
intraocular lens). Hydrogel properties (e.g. swelling) 
and drug release profiles are frequently related to the 
water content within the gel (Lee et al. 1975; Jhon & 
Andrade 1973; Shi et al. 2012). Drug loading into the 
hydrogel is also an important parameter that can 
influence by the solvents that are used (Lewis et al. 
2008). 
In this paper we report the preparation of hydrogel 
films made from two polymers that are widely used 
in contact and intraocular lens; 2-(hy-
droxyethyl)methacrylate (HEMA) and 2-metha-
cryloyloxyethyl phosphorylcholine (MPC) (Tomar et 
al. 2012; Stirbu et al. 2011; Schlenoff 2014; Ishihara et 
al. 1990; Lewis 2000). MPC has zwitterionic 
phosphoryl choline pendent chains that mimic lipid 
head groups and has been shown to be a 
biocompatible material (Schlenoff 2014). In addition 
to contact lens, MPC is used in a wide range of clinical 
products including coronary stents (Lewis et al. 2008).  
A range of HEMA-MPC films in this study were 
characterised for their water content, water 
distribution, water permeability and mechanical 
strength. Steroids such as dexamethasone are often 
used after GFS to moderate the inflammatory 
response. The HEMA-MPC films were loaded with 
dexamethasone and the release profiles were 
monitored using an in vitro model that mimics 
aqueous outflow of the GFS surgical area (bleb). 
MATERIALS AND METHODS 
Materials and Instrumentation 
Hydroxyethyl methacrylate (HEMA), poly(ethylene 
glycol dimethacrylate) (PEGDA, Mn 700), 2,2-azo-
bis(2-methylpropionitrile) (AIBN), dexamethasone 
and phosphate buffered saline (PBS) tablets were 
purchased from Sigma-Aldrich (Gillingham, UK). 2-
methacryloyloxyethyl phosphoryl choline (MPC, 
295.27 g/moL) was obtained from Vertellus 
Biomaterials (UK). 
UV measurements were performed using a Hitachi U-
2800A spectrometer using Quartz cuvettes (Starna 
Scientific Ltd). Scanning electron microscopy (SEM) 
was achieved using a QuantaTM 200F instrument (FEI 
Quanta200 FEGESEM, Eindhoven, The Netherlands). 
Mechanical properties were measured with an Instron 
Universal testing instrument (Model 5567, Instron 
Ltd, Norwood, USA) equipped with Bluehill software 
2 (version 6). Freeze-drying was conducted with a 
VIRTIS-Advantage freeze-dryer. Different scanning 
calorimetry (DSC) experiments were performed on 
DSC Q2000 (TA instruments, Waters, LLC) equipped 
with TA Instruments Universal Analysis 2000 
software. High performance liquid chromatography 
(HPLC) was conducted using an Agilent 1200 series 
(Agilent, Wokingham, Berkshire, UK) equipped with 
Chemstation software (Agilent, Wokingham, 
Berkshire, UK) using a Synergi 4u Hydro-RP 80 A (150 
× 4.60 mm, 4 micron) column (Phenomenex Co., 
California, USA). A 16-channel Ismatec peristaltic 
pump (Michael Smith Engineers Ltd., Woking, 
Surrey, UK) was used to generate fluid flow into the 
flow rigs. 
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Preparation of HEMA-MPC hydrogel films 
HEMA-MPC hydrogel films were prepared by 
thermally induced free radical polymerisation (Table 
1, Fig. 1). MPC monomer was dissolved in HEMA 
monomer and mixed till a clear solution was 
observed. PEGDA (crosslinker) and AIBN (initiator) 
were separately mixed till a clear mixture was 
observed. A septum was attached to the lid of the 
glass tube and an outlet needle 19G was placed at the 
top of the tube. The mixture was degassed with argon 
for 5 mins. The reaction mixture was then injected into 
a polypropylene mould using a 21G needle while 
avoiding the formation of air bubbles.  
Two polypropylene sheets and one silicone sheet 
were used to prepare the polypropylene mould (Fig. 
S1). The polypropylene and silicone sheets (1.0 mm 
thickness) were cut in rectangles with 4.0 × 9.0 cm 
dimensions. The inside of the silicone sheet was 
further cut into another rectangle, 3.0 × 8.0 cm, leaving 
a distance of 1.0 cm from the borders.  Before 
assembling the sheets, they were sonicated with 
isopropanol (10 mins) and dried in the oven at 50°C 
(30 mins). The silicone sheet was sandwiched between 
the two polypropylene sheets and the polymer 
mixture was injected slowly from the edges. 
 
Fig. 1. Synthesis of HEMA-MPC hydrogel films by free radical 
polymerisation. The two monomers (HEMA and MPC) were 
mixed with the crosslinker (PEGDA) to form a clear solution. 
AIBN (initiator) was added and placed in the oven at 70°C for 6 
hours. 
Upon adding the reaction mixture, the mould was 
then placed flat in the oven at 70°C for 6 hours to 
conduct the polymerisation and form the xerogel 
(hydrogel in a completely dried state). The xerogel 
was gently removed, hydrated in water (50 mL) and 
the leachables removed by washing. The water was 
changed twice daily for 4 days and the washed 
fractions were scanned with UV-Vis spectroscopy 
(200-400 nm) to detect any unreacted monomers. The 
hydrogels were considered clean when the washed 
fractions showed no signal with UV and were stored 
in plastic containers in water (50 mL) prior to further 
use. The storage water was changed every week to 
avoid bacterial growth. 
Table 1. Compositions of different HEMA-MPC hydrogel films prepared by free radical polymerisation 
Code HEMA (M) MPC (M) PEGDA (mM) AIBN (g) MPC (%) 
S1 8.1 0.0 8.0 0.074 0 
S2 7.8 0.1 8.0 0.074 5 
S3 7.4 0.3 8.0 0.074 10 
S4 7.0 0.5 8.0 0.074 15 
S5 6.6 0.7 8.0 0.074 20 
S6 5.7 1.0 8.0 0.074 30 
S7 4.1 1.7 8.0 0.074 50 
S8 0.0 0.3 8.0 0.074 100 
Characterisation of the hydrogel films  
Mechanical testing  
Film pieces in a dog bone shape were used to avoid 
having a break in the area being gripped and they 
were cut from fully hydrated films. The dimensions of 
each sample were 15.5 × 3.6 × 1.0 mm (length × width 
× thickness respectively). Each sample was placed 
between the clamps of the Instron and pulled apart at 
a rate of 10.0 mm/min and 100.0 N static load (2 kg). 
Samples mounted on the grips were sprayed with 
water to ensure they remained fully hydrated. The 
cut-off point was when the film was completely 
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separated into two pieces. The tensile modulus of 
elasticity (represented by Young’s modulus) was 
determined as the slope of the linear part of the stress–
strain curve. 
Distribution of water inside the hydrogel, free to 
bound water ratio 
DSC can measure the free to bound water ratio of 
hydrogels. Only free water (Wf) and moderately 
bound water (Wb) are frozen so the endotherm 
obtained from DSC represents the amount of frozen 
water only. Eq. 1 assumes that the heat of fusion of 
frozen hydrogel water is the same as ice. The amount 
of Wb is the difference between the total water content 
and frozen water. The melting enthalpies achieved 
from DSC are used to calculate the Wb to Wf ratio (Eq. 
1): 
𝑊𝑏 (%) = 𝐸𝑊𝐶% − (𝑊𝑓 + 𝑊𝑓𝑏) × 100 
𝑊𝑏(%) = 𝐸𝑊𝐶% − (
𝑄𝑒𝑛𝑑𝑜
𝑄𝑓
) × 100 
Eq. 1 
Where, Wf is the amount of free water, Wfb is the 
amount of lightly bound water, Qendo is the melting 
enthalpies derived from the DSC chart and Qf is the 
melting enthalpies of free water, which similar to ice 
(79.9 cal/g) (Rohindra et al. 2004). Experiments were 
performed at a heating rate of 3.0°C/min from -40 to 
20°C. Calibration with indium (Tm = 156.6, ∆Hf =28.71 
J/g) was performed according to the manufacturer 
instructions. Nitrogen was purged gas at 50 mL/min. 
TA zero aluminium hermetic pans and lids were used.  
Scanning electron microscopy (SEM) 
The dried samples were cut and adhered onto alu-
minium SEM stubs using carbon-coated double-sided 
tape. They were sputter coated with gold prior to 
imaging to make them electrically conductive 
Equilibrium water content (EWC%) 
Equilibrium water content percentage (EWC%) is the 
percentage of water absorbed by a xerogel at full hy-
dration. Hydrogel discs (1.0 cm in diameter) were cut 
from fully hydrated hydrogel films and weighed, to 
give hydrated equilibrium weight (We). The discs 
were dried in a vacuum oven at 70°C until they 
reached constant weight (Wd). EWC% was calculated 
using Eq. 2.  
𝐸𝑊𝐶% = (
𝑊𝑒 − 𝑊𝑑
𝑊𝑒
) × 100 
Eq. 2 
Swelling ratio (SR)  
Swelling ratio (SR) is the ratio between the weight of 
solvent absorbed by the hydrogel and the dry weight 
of the hydrogel. It gives an indication to the increase 
in size of the dry xerogel when fully hydrated. Hy-
drogel discs (1.0 cm in diameter) were cut at ambient 
temperature from a fully hydrated hydrogel film, 
weighed and dried in a vacuum oven at 70°C until 
reaching a constant weight (Wd). Different water 
miscible alcohols were investigated to see the 
difference in SR. The dry discs were incubated in a 
solvent (5.0 mL) i.e. water, methanol, ethanol, water: 
methanol (1:1) or water: ethanol (1:1) for 48 hours 
(25°C) to become hydrated. The discs were removed; 
carefully wiped and weighed at equilibrium (We). The 
SR was calculated using Eq. 3.  
𝑆𝑅 = (
𝑊𝑒 − 𝑊𝑑
𝑊𝑑
) 
Eq. 3 
Drug loading and release from 10% MPC hydrogels  
Dexamethasone is a poorly water-soluble drug (~0.1 
mg/mL). Water:ethanol (1:1) was used to improve the 
loading efficiency of dexamethasone in the 10% 
HEMA-MPC hydrogel with a solubility increase to 1.0 
mg/mL. Two methods were used to estimate the 
loading efficiency and the amount of dexamethasone 
loaded in each disc. One method was based on the 
difference in UV reading between the starting solution 
and the solution left after incubation. This approach 
assumes that the difference between the readings 
represents the amount loaded in the disc. The other 
method is based on complete extraction of 
dexamethasone from the loaded discs using 
methanol. Methanol was used as extraction solvent 
because the discs swell to a higher extent in methanol 
compared to water or PBS. 
Discs of 1.0 mm × 1.0 cm (thickness × diameter) were 
dried at 70°C in vacuum for 24 hours. The discs were 
then soaked in drug solution for 24 hours. Water: 
ethanol (1:1) and methanol were used to load 1.0 and 
15.0 mg/mL of dexamethasone respectively. With 
water:ethanol system, the discs were carefully 
removed from drug solution after incubation and 
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placed in deionised water (5.0 mL) for 30 sec to 
remove unbound drug. The discs were dried at 
ambient temperature (~25°C) under vacuum for 24 
hours. With methanol system, the discs were removed 
from the incubation solution and placed in ethanol 
(4.0 mL) for 1 min to remove unbound drug. They 
were placed in deionised water (2.0 mL) for 4 hours 
and dried under vacuum for 24 hours. The amount of 
drug loaded for each disc was calculated as the 
difference in UV absorbance reading between the 
starting solution and the solution left after loading. 
The loading efficiency was also calculated using Eq. 4. 
𝐿𝑜𝑎𝑑. 𝑒𝑓𝑓. = (
𝑎𝑚𝑜𝑢𝑛𝑡 𝑙𝑜𝑎𝑑𝑒𝑑
𝑎𝑐𝑡𝑢𝑎𝑙 𝑎𝑚𝑜𝑢𝑛𝑡 𝑖𝑛 𝑙𝑜𝑎𝑑𝑖𝑛𝑔 𝑠𝑜𝑙.
) × 100  
Eq. 4 
HPLC method for dexamethasone  
The mobile phase composed of acetonitrile and 
aqueous trifluoroacetic acid (TFA) solution (0.1% v/v) 
at 40:60 volumetric ratio. The flow rate was 1.0 
mL/min with an injection volume of 10.0 L, a UV 
detection wavelength of 240 nm and a temperature of 
40°C. The retention time for dexamethasone was 4.8 
min. A calibration curve with HPLC and UV were 
plotted with a drug concentration range of 3.0-100.0 
g/mL (R2=1) and 1.5-25.0 g/mL (R2: 0.999) in water 
respectively.  
Hydrogel release of dexamethasone  
Release studies were performed in an in house flow 
rig model (Fig. 2) that mimics the bleb formed after 
GFS. There is no reported eye model to study the 
release of formulations in the anterior segment. Our 
rig models have been previously characterised and 
extensively used during the evaluation of 
formulations targeted to the anterior segment of the 
eye. The rigs were rinsed, cleaned and dried prior to 
each experiment. The model was disassembled by 
removing the screws. The rigs were assembled again 
after placing the drug loaded discs. All rigs were 
placed in a pre-heated oil bath at 37°C and 
temperature was monitored with a thermometer. The 
ports had a small inner diameter (0.92 mm) to ensure 
the size did not significantly enlarge the volume of the 
chamber. An inlet port allows a flow rate similar to 
that in the subconjunctival space (2.0 μL/min) 
(Brubaker 1982; Toris et al. 1999; Maurice 2001; 
Siggers & Ethier 2012; Ethier et al. 2004). Constant 
flow of PBS (pH 7.4, at 37°C) supplemented with 
sodium azide (0.02%) was provided. The volume (50-
400 μL) and shape of blebs varies among individuals, 
therefore, to obtain consistent results the rigs were 
round with a capacity of 400 μL. An outlet port was 
present for sample collection and samples were 
quantified with HPLC (240 nm). 
 
Fig. 2. Schematic representation of the flow rig used for the release 
studies. Each hydrogel was placed into a rig, which was 
continuously supplied with phosphate buffered saline (PBS, pH 
7.4, 37°C) at 2.0 μL/min using a peristaltic pump to mimic 
subconjunctival aqueous outflow. Aliquots were collected at 
predetermined time points from the outlet tube and analysed by 
HPLC. 
Data analysis 
All results are presented as the mean and standard 
deviation (± STD) from triplicate (n=3) unless stated 
otherwise. Data was plotted using OriginPro 9.1 
(software, Origin lab cooperation, USA) and the half-
life (t½) was calculated according to the best fitting 
model in OriginPro. First-order kinetic rate constants 
(k) were derived from the mono-exponential curve 
and t½ was calculated with t½ =0.693/k. The analysis of 
variance (one-way and repeated measure ANOVA) 
with Tukey’s post hoc test was conducted to evaluate 
differences between the experimental data (mean 
values) using OriginPro 9.1 and IBM SPSS statistics 23. 
Probability values less than 0.05 (p<0.05) were 
considered as indicative of statistically significant 
differences.  
RESULTS AND DISCUSSION 
Hydrogels derived from MPC and HEMA monomers 
that are crosslinked with PEGDA are hydrophilic. 
Total water content and distribution within a 
hydrogel are important properties needed to optimise 
drug loading and release properties. Variation of the 
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structure and stoichiometry of either monomer or the 
crosslinker can influence hydrogel properties. 
Hydrogels were prepared via free radical 
polymerisation using AIBN and the relative MPC to 
HEMA monomer ratio was varied (Fig. 1). 
Hydrogels were prepared using moulds to give flat 
sheets and hydrogel films were obtained after 
hydration. The relative monomer proportion of MPC 
was varied from 0 to 100%. Hydrogels prepared using 
0 to 50% MPC (labelled S1 to S7, Table 1) were hard 
and glassy prior to hydration. One hydrogel (S8) 
prepared with 100% MPC was jelly-like in consistency 
and was not a hard film as a xerogel. The thickness of 
all of the xerogels (S1 to S7) was 1.1 ± 0.1 mm. When 
fully hydrated, formulations S1 to S6 remained intact 
as films, however the 50% MPC film (S7) was fragile 
and easily breakable. As an example of hydration 
time, the fully dried 10% MPC hydrogel requires at 
least 6 hours to reach maximum hydration and 30 
minutes to reach around 50% of hydration when 
placed in PBS at 25 C. The thickness of the hydrogel 
films increased with increasing MPC content upon 
hydration (Table 1) indicating that there was more 
water associated with MPC compared to HEMA.  
The number and size of pores increased with 
increasing MPC (Fig. 3A). Larger pores would allow 
more water to pass through with a higher percentage 
of free water being entrapped within the films. The 
water content and mechanical strength are both 
important when considering an implantable hydrogel 
that must also release drug. As crosslinked materials, 
hydrogels can be susceptible to tearing, so we also 
characterised Young’s modulus of the gels.  Water 
content and knowledge of the bulk (free) and bound 
water are also important when considering the use of 
a hydrogel in drug delivery. 
Mechanical properties results 
A decrease in Young’s modulus in the prepared 
hydrogels was seen with increasing relative amounts 
of MPC (Fig. 3B). These results are consistent with the 
previously reported data for contact lens (Hamilton & 
Pye 2008; Monti & Simonib 1992). The reported 
Young’s modulus values were 0.8 and 0.5 MPa for 
HEMA and Proclear® contact lenses with 15% MPC 
respectively (Young et al. 2010; Tranoudis & Efron 
2004).   High  MPC   containing   hydrogels  (50%, S7) 
easily broke apart upon hydration. The zwitterionic 
charged MPC phosphoryl choline pendent chains 
readily associate with water and may not sufficiently 
interact with the hydroxyethyl pendent chains from 
HEMA. The presence of PEGDA derived crosslinks 
also inhibits interactions between polymer chains. 
Increased internal water reduces polymer-polymer 
chain association resulting in reduced mechanical 
strength of the formed gels (Monti & Simonib 1992). 
Water distribution measurements  
The effects of MPC on the bound to bulk water ratio 
were determined by DSC (Fig. 3C and Table 2). As the 
relative percentage of MPC increased there was an 
increase in the bulk free water ratio compared to 
bound water. The increased amount of zwitterionic 
MPC pendent chain results in an increase in bulk 
water (Shi et al. 2012; Chen et al. 2010). The primary 
hydroxy group in the HEMA pendent chain can also 
form hydrogen bonds with water. As the hydrogel 
becomes more hydrated due to increased bound 
water due to MPC, there may also be increased 
solubilisation of the HEMA pendent chain to further 
increase the bulk water content of the hydrogel.  
Equilibrium water content (EWC) and swelling ratio 
(SR) measurements 
To better quantitate water content, the EWC (left 
panel) and the SR (right panel) of the prepared 
hydrogels (S1-S7) were determined (Fig. 3D). There 
was significant increase (p<0.05) in both EWC and SR 
with increasing MPC. In other MPC co-polymers, a 
dramatic increase in water content was observed 
when MPC was copolymerised with hydrophobic 
monomers such as n-butyl methacrylate (Ishihara et 
al. 1990). The zwitterionic phosphoryl choline 
pendent chains of MPC results in bound water 
associations and this bound water forms hydrogen 
bonds with other water molecules. There is essentially 
a continuum of bound water to less bound and then 
to bulk water. It is thought that most water is in the 
free (bulk) form (Morisaku et al. 2008) in MPC rich 
polymers. The hydroxyethyl pendent chain on HEMA 
once incorporated into a polymer is also hydrophilic, 
but less so than the phosphoryl choline MPC pendent 
chain. The amount of MPC dominates the changes in 
overall water content in these HEMA-MPC hydrogels. 
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Mixed aqueous solvents on the swelling ratio (SR)  
Some drugs are more soluble in water miscible 
solvents such as methanol and ethanol than in water 
alone. Polymer pendent chain solubilisation and 
solvent association properties in the hydrogels would 
be expected to differ in these alcoholic solvents. The 
SR as a function of the relative amount of MPC was 
also determined in methanol, ethanol, water: 
methanol (1:1) and water:ethanol (1:1) (Fig. 4 and 
Table S1).  
 
Table 2. The ratio of bound to free water in a hydrogel films based on MPC% 
MPC (%) 0 5 10 15 20 30 50 
Wb:Wf  1:0.3 1:1.2 1:1.8 1:2.5 1:3.2 1:4.1 1:6.8 
Abbreviation: Wb: bound water and Wf: free water 
 
A  
B  C  
D   
Fig. 3. The effect of MPC% on (A) pore size analysed by SEM (scale bar is 40 µm), (B) Young’s modulus values, (C) free bulk water (Wf) 
and bound water (Wb) and (D) EWC % as measured using eq. 2 and (right panel) on SR as measured using eq. 3. All results are displayed 
as the average of the triplicate (n=3) and standard deviation (±STD).  
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Fig. 4. The effect of solvent used on SR of films (n=3 ±SD) with 
different percentages of MPC (top) and example SRs of 10% MPC 
in the different solvents (bottom).  
The methanol SR was greater than the ethanol SR. 
There was little variation in the methanol SR with 
increasing MPC monomer content while the ethanol 
SR slightly decreased with increasing MPC monomer 
content. The methanol and ethanol SRs contrasts with 
the SR of water, which increased with increasing 
MPC. The water SR became greater than the methanol 
SR at relative MPC monomer contents above 10%. In 
100% MPC hydrogels both methanol and ethanol 
were also taken up less than water alone (Kiritoshi & 
Ishihara, 2003). 
The 1:1 mixed alcohol-water SRs were higher than 
water up to 50% MPC and also displayed increasing 
SR with increasing MPC content.  Bulk alcohol 
association around the zwitterionic MPC pendent 
chain is thought to be less than water association due 
to decreased hydrogen bonding of the alcohol. It is 
possible that the ethyl-hydroxy HEMA pendent 
chains are better solubilised by methanol and ethanol 
than water. The increased solubilisation of the ethyl-
hydroxy HEMA pendent chains by alcohol allowed 
the influx of miscible water resulting in greater SRs up 
to the threshold SR at 50% MPC monomer 
incorporation. The implication is that water is better 
associated with the MPC pendent chain and that 
alcohol is better associated with the HEMA pendent 
chain. 
Dexamethasone loading and in vitro release of 
hydrogel films 
High water content and a low mechanical strength 
were observed for the 20 and 30% MPC films. 
Suboptimal mechanical strength is not desired for an 
implantable device. Although there was no significant 
difference in the EWC% and SR of 10 and 15% MPC 
films, the 15% MPC films displayed more free water 
compared to bound water, which is thought to 
decrease the mechanical strength of the hydrogel. The 
10% MPC film was thus selected for further study to 
determine the release profile of dexamethasone. 
In an effort to increase the drug loading and to 
prolong the release of dexamethasone, the discs were 
incubated in a dexamethasone-methanol solution (15 
mg/mL, volume: 1.0 mL). The dexamethasone 
saturated HEMA-MPC discs were rinsed with water 
(1.0 mL for 4 hours) to remove methanol. Removal of 
methanol resulted in the precipitation of 
dexamethasone inside the disc. The precipitated 
dexamethasone within the HEMA-MPC hydrogel 
disc created a depot. The initial amount of 
dexamethasone loaded in each disc before washing 
with water was 2.1 mg. Dexamethasone lost during 
washing was 0.2 mg (10% of the loaded drug). The 
final loading after washing was 1.9 mg which is 6 
times higher compared to using water:ethanol as 
loading solution. The release of dexamethasone was 
also sustained and the t½ was 9.7 days. The depot 
created with dexamethasone helped to prolong 
dexamethasone release in a more controlled manner.  
Storage and delivery of hydrogel films 
One of the problems associated with hydrogels is their 
delivery in the clinic and storage stability prior to 
surgery. A dry 10% MPC hydrogel requires 30 mins to 
reach approximately 50% hydration at least 6 hours to 
reach maximum hydration when placed in PBS at 
25°C (Fig. S2). Although placing a hydrogel in a 
storage solution will be more convenient for use in the 
Dry  
Water:Methanol (1:1) 
Water:Ethanol (1:1) 
Ethanol 
Methanol 
Water 
Hydrated  
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Concentration (mg/mL) Cumulative release (%) 
Fig. 5: HPLC results of in vitro release of dexamethasone from 10% MPC films using methanol versus water:ethanol. All results are 
displayed as the average of the triplicate (n=3) and standard deviation (±STD). 
Table 3. The amount loaded and loading efficiency of DEX in 10% MPC discs calculated using two different methods (UV and extraction).  
Method Amount loaded (mg) Loading efficiency (%) 
UV 0.3 ± 0.03 30.0 
Extraction with methanol 0.4 ± 0.10 39.0 
Note: No significant difference (p>0.05) was observed in the amount loaded and loading efficiency between the two methods.  
clinic, the stability of loaded drugs inside a hydrated 
hydrogel would be a problem. Some of the drug 
loaded will diffuse from the hydrogel matrix to the 
storage solution during storage and reduce the 
amount loaded. The best method is to deliver the 
hydrogel spacer in dry form with instructions to 
rehydrate them in 0.5 mL sterilised water for 1 hour 
prior to use to avoid drug hydrolysis. The hard glassy 
nature of dry hydrogels may cause irritation and 
discomfort if placed in dry form so rehydration for 1 
hour prior to use would ensure at least 50% of 
swelling is achieved without drug loss. 
CONCLUSION 
Hydrogels derived from HEMA-MPC crosslinked 
with PEDGA were made by free radical 
polymerisation using varying amounts of MPC 
ranging from 0 to 100%. The pore size of the hydrogel 
films increased with increasing MPC, and hydrated 
films were difficult to fabricate with hydrogels made 
with greater than 30% MPC. Increased MPC also 
resulted in an increased SR and EWC%, but with 
lower water permeability. It was found that 10% MPC 
was optimal for further evaluation with 
dexamethasone using two different solvents to 
maximise drug loading. It is known that the use of this 
amount of MPC is enough to impart biocompatibility 
properties, which can be beneficial during GFS. The 
loaded dexamethasone increased from 0.3 to 1.9 
mg/disc when the solvent changed from 
water:ethanol (1:1) to methanol, with an in vitro t½ 
increased from 1.9 to 9.7 days respectively. The results 
obtained in this study demonstrate the possibility of 
extending the duration of action of a hydrogel 
formulation of dexamethasone by increasing the drug 
loading within the hydrogel.  
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SUPPLEMENTARY MATERIAL 
 
Fig. S1. The mould used for the hydrogel fabrication before and 
after assembly. The mould consists of two polypropylene sheets 
and one silicone sheet sandwiched between them. 
 
 
 
Fig. S2. The swelling and deswelling behaviour of 10% MPC 
hydrogel. All results are displayed as the average of the 
triplicate (n=3) and standard deviation (±STD). 
 
Table S1. The swelling ratio (SR) of S1 to S6 films in different solvent and solvent systems 
 
Solvent system 
MPC (%) 
0 5 10 20 30 50 
Water 0.6 ± 0.01 0.9 ± 0.003 1.2 ± 0.02 1.9 ± 0.3 2.8 ± 0.2 4.8 ± 0.1 
Methanol 1.3 ± 0.04 1.3 ± 0.03 1.2 ± 0.1 1.2 ± 0.1 1.1 ±  0.02 1.6 ± 0.01 
Water: Methanol (1:1) 2.0 ± 0.07 2.4 ± 0.1 2.8 ± 0.1 3.1 ± 0.1 3.9 ± 0.1 4.6 ± 0.1 
Water: Ethanol (1:1) 3.3 ± 0.4 3.3 ± 0.1 3.3 ± 0.1 3.9 ± 0.1 4.0 ± 0.03 4.5 ± 0.1 
Ethanol 0.4 ± 0.03 0.2 ± 0.01 0.2 ± 0.03 0.2 ± 0.02 0.1 ±  0.01 0.04 ± 0.01 
 
 
6 
 
Table 2:2 Compositions of different HEMA-MPC hydrogel films prepared by free radical 
polymerization.  
Code HEMA (M) MPC (M) PEGDA (mM) AIBN  (g) MPC% 
S1 8.1 0 8 0.074 0 
S2 7.8 0.14 8 0.074 5 
S3 7.4 0.3 8 0.074 10 
S4 7 0.48 8 0.074 15 
S5 6.6 0.65 8 0.074 20 
S6 5.7 0.99 8 0.074 30 
S7 4.1 1.67 8 0.074 50 
S8 0 0.34 8 0.074 100 
Abbreviation: Hydroxyethyl methacrylate (HEMA), polyethylene glycol dimethacrylate-700 Da 
(PEGDA), 2,2-azobis(2-methylpropionitrile) (AIBN), 2-methacryloyloxyethyl phosphoryl choline 
(MPC).  
To prepare the polypropylene mould two polypropylene sheets and one silicone sheet 
were used. The polypropylene sheets were rectangular in shape (4x9 cm). A silicone 
sheet (1.0 mm thickness) was cut into a rectangle (4x9 cm). The inside of the silicone 
sheets was then cut into another rectangle (3x8 cm) leaving 1 cm distance from the 
borders. The mould was assembled together by sandwiching the silicone sheet 
between the two polypropylene ones Figure 2:3. Both polypropylene and silicone 
sheets were first sonicated with isopropanol for 10 minutes to clean them then dried in 
the oven at 50oC for 30 minutes. After assembling the mould the polymer mixture was 
injected slowly and carefully starting from the edges to avoid air bubbles. 
Figure 2:3 The mould used for the hydr l f rication before and after assembly. The mould 
consists of two polypropylene sheets and one silicone sheet sandwiched between them. 
Polypropylene sheet 
Silicone sheet 
